Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury

Frontiers in Physiology

Volumn APR, Issue , 2011, Pages

  Camara, Amadou K S ^a   Bienengraeber, Martin ^a   Stowe, David F ^a,b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Medical College of Wisconsin and Marquette University   (United States)

Author keywords

Cardiac ischemia reperfusion; Cardiac metabolism; Mitochondria; Mitochondrial ca 2+; Nitric oxide; Peroxynitrite; Reactive oxygen species; Therapy

Indexed keywords

EID: 80054978144     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00013     Document Type: Article

References (358)

1. Abozguia, K., Clarke, K., Lee, L., and Frenneaux, M. (2006). Modification of myocardial substrate use as a therapy for heart failure. Nat. Clin. Pract. Cardiovasc. Med. 3, 490-498.
2. Aldakkak, M., Heisner, J. S., Camara, A. K. S., Haumann, J., and Stowe, D. F. (2009). Ranolazine, a late sodium current inhibitor, reduces ischemia-induced superoxide emission and improves functional recovery in guinea pig hearts. FASEB J. Abstract 23, 93.17.
3. 2+ overload and ROS release. Cardiovasc. Res. 77, 406-415.
4. + exchange during ischemia and reperfusion impairs mitochondrial bioenergetics and myocardial function. J. Cardiovasc. Pharmacol. 52, 236-244.
5. 2+ loading but does little to better protect function on reperfusion. FASEB J. Abstract 22, 730.24.
6. 2+-activated K+ channel opening. Am. J. Physiol. Cell Physiol. 298, C530-C541.
7. Ambrosio, G., Zweier, J. L., Duilio, C., Kuppusamy, P., Santoro, G., Elia, P. P., Tritto, I., Cirillo, P., Condorelli, M., and Chiariello, M. (1993). Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J. Biol. Chem. 268, 18532-18541.
8. Andreyev, A. Y., Kushnareva, Y. E., and Starkov, A. A. (2005). Mitochondrial metabolism of reactive oxygen species. Biochemistry Mosc. 70, 200-214. [Review].
9. Aon, M. A., Cortassa, S., Akar, F. G., and O'Rourke, B. (2006a). Mitochondrial criticality: a new concept at the turning point of life or death. Biochim. Biophys. Acta 1762, 232-240.
10. Aon, M. A., Cortassa, S., and O'Rourke, B. (2006b). The fundamental organization of cardiac mitochondria as a network of coupled oscillators. Biophys. J. 91, 4317-4327.
11. Aon, M. A., Cortassa, S., Maack, C., and O'Rourke, B. (2007). Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J. Biol. Chem. 282, 21889-21900.
12. Aon, M. A., Cortassa, S., Marban, E., and O'Rourke, B. (2003). Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 278, 44735-44744.
13. Archer, S. L., Gomberg-Maitland, M., Maitland, M. L., Rich, S., Garcia, J. G., and Weir, E. K. (2008). Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am. J. Physiol. Heart Circ. Physiol. 294, H570-H578.
14. Armstrong, J. S. (2008). Mitochondria-directed therapeutics. Antioxid. Redox Signal. 10, 575-578.
15. Ashrafian, H., Frenneaux, M. P., and Opie, L. H. (2007). Metabolic mechanisms in heart failure. Circulation 116, 434-448.
16. Azoulay-Zohar, H., Israelson, A., Abu-Hamad, S., and Shoshan-Barmatz, V. (2004). In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem. J. 377(Pt 2), 347-355.
17. 2 reaction. J. Bioenerg. Biomembr. 25, 71-80.
18. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., Robbins, J., and Molkentin, J. D. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662.
19. Balaban, R. S. (1990). Regulation of oxidative phosphorylation in the mammalian cell. Am. J. Physiol. 258(Pt 1), C377-C389.
20. Balaban, R. S., Kantor, H. L., Katz, L. A., and Briggs, R. W. (1986). Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 232, 1121-1123.
21. Barreiro, E., Garcia-Martinez, C., Mas, S., Ametller, E., Gea, J., Argiles, J. M., Busquets, S., and Lopez-Soriano, F. J. (2009). UCP3 overexpression neutralizes oxidative stress rather than nitrosative stress in mouse myotubes. FEBS Lett. 583, 350-356.
22. Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A., and Bernardi, P. (2005). Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J. Biol. Chem. 280, 18558-18561.
23. Bastianetto, S., Zheng, W. H., and Quirion, R. (2000). Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br. J. Pharmacol. 131, 711-720.
24. Baumgart, K., Georgieff, M., Radermacher, P., and Calzia, E. (2009). Cardioprotection by hydrogen sulfide: suspended animation, inflammation, and apoptosis. Shock 31, 218-219.
25. Beadle, R. M., and Frenneaux, M. (2010). Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease. Heart 96, 824-830.
26. Beard, D. A. (2006). Modeling of oxygen transport and cellular energetics explains observations on in vivo cardiac energy metabolism. PLoS Comput. Biol. 2, e107. doi: 10.1371/ journal.pcbi.0020107
27. Beard, D. A., and Kushmerick, M. J. (2009). Strong inference for systems biology. PLoS Comput. Biol. 5, e1000459. doi: 10.1371/journal.pcbi.1000459
28. Belzacq, A. S., Vieira, H. L., Verrier, F., Vandecasteele, G., Cohen, I., Prevost, M. C., Larquet, E., Pariselli, F., Petit, P. X., Kahn, A., Rizzuto, R., Brenner, C., and Kroemer, G. (2003). Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res. 63, 541-546.
29. Benov, L., Sztejnberg, L., and Fridovich, I. (1998). Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med. 25, 826-831.
30. Beraud, N., Pelloux, S., Usson, Y., Kuznetsov, A. V., Ronot, X., Tourneur, Y., and Saks, V. (2009). Mitochondrial dynamics in heart cells: very low amplitude high frequency fluctuations in adult cardiomyocytes and flow motion in non beating Hl-1 cells. J. Bioenerg. Biomembr. 41, 195-214.
31. Bersin, R. M., and Stacpoole, P. W. (1997). Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am. Heart J. 134(Pt 1), 841-855.
32. Bian, J. S., Yong, Q. C., Pan, T. T., Feng, Z. N., Ali, M. Y., Zhou, S., and Moore, P. K. (2006). Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. Pharmacol. Exp. Ther. 316, 670-678.
33. Bianchi, P., Kunduzova, O., Masini, E., Cambon, C., Bani, D., Raimondi, L., Seguelas, M. H., Nistri, S., Colucci, W., Leducq, N., and Parini, A. (2005). Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 112, 3297-3305.
34. Bing, R. J. (1965). Cardiac metabolism. Physiol. Rev. 45, 171-213.
35. Blaikie, F. H., Brown, S. E., Samuelsson, L. M., Brand, M. D., Smith, R. A., and Murphy, M. P. (2006). Targeting dinitrophenol to mitochondria: limitations to the development of a self-limiting mitochondrial protonophore. Biosci. Rep. 26, 231-243.
36. Boss, O., Samec, S., Paoloni-Giacobino, A., Rossier, C., Dulloo, A., Seydoux, J., Muzzin, P., and Giacobino, J. P. (1997). Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408, 39-42.
37. Brady, N. R., Hamacher-Brady, A., and Gottlieb, R. A. (2006a). Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim. Biophys. Acta 1757, 667-678.
38. Brady, N. R., Hamacher-Brady, A., Westerhoff, H. V., and Gottlieb, R. A. (2006b). A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxid. Redox Signal. 8, 1651-1665.
39. Bremer, J. (1969). Pyruvate dehydrogenase, substrate specificity and product inhibition. Eur. J. Biochem. 8, 535-540.
40. Bremer, J., and Wojtczak, A. B. (1972). Factors controlling the rate of fatty acid-oxidation in rat liver mitochondria. Biochim. Biophys. Acta 280, 515-530.
41. Brenner, C., Cadiou, H., Vieira, H. L., Zamzami, N., Marzo, I., Xie, Z., Leber, B., Andrews, D., Duclohier, H., Reed, J. C., and Kroemer, G. (2000). Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19, 329-336.
42. Bristow, M. (2000). Etomoxir: a new approach to treatment of chronic heart failure. Lancet 356, 1621-1622.
43. Brookes, P. S. (2005). Mitochondrial H+ leak and ROS generation: an odd couple. Free Radic. Biol. Med. 38, 12-23. [Review].
44. Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., and Sheu, S. S. (2004). Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287, C817-C833. [Review].
45. Brown, D. A., and O'Rourke, B. (2010). Cardiac mitochondria and arrhythmias. Cardiovasc. Res. 88, 241-249.
46. Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhausl, W., and Furnsinn, C. (2004). Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53, 1052-1059.
47. Bryson, J. M., Coy, P. E., Gottlob, K., Hay, N., and Robey, R. B. (2002). Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death. J. Biol. Chem. 277, 11392-11400.
48. Burelle, Y., Khairallah, M., Ascah, A., Allen, B. G., Deschepper, C. F., Petrof, B. J., and Des Rosiers, C. (2009). Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. J. Mol. Cell. Cardiol. 48, 310-321.
49. Burwell, L. S., and Brookes, P. S. (2008). Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid. Redox Signal. 10, 579-599.
50. Burwell, L. S., Nadtochiy, S. M., and Brookes, P. S. (2009). Cardioprotection by metabolic shut-down and gradual wake-up. J. Mol. Cell. Cardiol. 46, 804-810.
51. Cadenas, E., Boveris, A., Ragan, C. I., and Stoppani, A. O. (1977). Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180, 248-257.
52. Cadenas, E., and Davies, K. J. (2000). Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29, 222-230. [Review].
53. Cadoudal, T., Distel, E., Durant, S., Fouque, F., Blouin, J. M., Collinet, M., Bortoli, S., Forest, C., and Benelli, C. (2008). Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes 57, 2272-2279.
54. Calabrese, V., Lodi, R., Tonon, C., D'Agata, V., Sapienza, M., Scapagnini, G., Mangiameli, A., Pennisi, G., Stella, A. M., and Butterfield, D. A. (2005). Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 233, 145-162.
55. Calvert, J. W., Coetzee, W. A., and Lefer, D. J. (2010). Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid. Redox Signal. 12, 1203-1217.
56. Calvert, J. W., Gundewar, S., Jha, S., Greer, J. J., Bestermann, W. H., Tian, R., and Lefer, D. J. (2008). Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 57, 696-705.
57. 2+ overload, and changes in redox state. Am. J. Physiol. Cell Physiol. 292, C2021-C2031.
58. Camara, A., Aldakkak, M., and Stowe, D. (2010a). "Mitochondria as potential therapeutic targets in mitochondria-related diseases," in Mitochondrial Structure, Function and Dysfunction, ed. O. L. Svensson (Milwaukee: Nova Science), 471-552.
59. Camara, A., Lesnefsky, E., and Stowe, D. (2010b). Potential therapeutic benefits of strategies directed to mitochondria. Antioxid. Redox Signal. 13, 279-347.
60. Camara, A., Kevin, L., Novalija, E., Varadarajan, S., and Stowe, D. (2002). Cold perfusion of isolated hearts generates reactive oxygen species but reduces generation and release during and after cold ischemia. Circulation, 106(Suppl. 2), SII-202.
61. Camara, A. K., Riess, M. L., Kevin, L. G., Novalija, E., and Stowe, D. F. (2004). Hypothermia augments reactive oxygen species detected in the guinea pig isolated perfused heart. Am. J. Physiol. Heart Circ. Physiol. 286, H1289-H1299.
62. 2+ signaling. Am. J. Physiol. Cell Physiol. 291, C1082-C1088. [Review].
63. Carpi, A., Menabo, R., Kaludercic, N., Pelicci, P., Di Lisa, F., and Giorgio, M. (2009). The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim. Biophys. Acta 1787, 774-780.
64. Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., and Shah, A. M. (2006). NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 8, 691-728.
65. Chamulitrat, W. (2001). EPR studies of nitric oxide interactions of alkoxyl and peroxyl radicals in in vitro and ex vivo model systems. Antioxid. Redox Signal. 3, 177-187.
66. Chen, L., and Knowlton, A. A. (2010). Mitochondria and heart failure: new insights into an energetic problem. Minerva Cardioangiol. 58, 213-229.
67. Chen, Q., Camara, A. K., Stowe, D. F., Hoppel, C. L., and Lesnefsky, E. J. (2007). Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am. J. Physiol. Cell Physiol. 292, C137-C147. [Review].
68. Chen, Q., Moghaddas, S., Hoppel, C. L., and Lesnefsky, E. J. (2006). Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J. Pharmacol. Exp. Ther. 319, 1405-1412.
69. Chen, Q., Moghaddas, S., Hoppel, C. L., and Lesnefsky, E. J. (2008). Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am. J. Physiol. Cell Physiol. 294, C460-C466.
70. Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., and Lesnefsky, E. J. (2003). Production of reactive oxygen species by mitochondria: central role of complex III. J. Biol. Chem. 278, 36027-36031.
71. Chen, Q., Yin, G., Stewart, S., Hu, Y., and Lesnefsky, E. J. (2010). Isolating the segment of the mitochondrial electron transport chain responsible for mitochondrial damage during cardiac ischemia. Biochem. Biophys. Res. Commun. 397, 656-660.
72. Chen, Z., Zhang, H., Lu, W., and Huang, P. (2009). Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim. Biophys. Acta 1787, 553-560.
73. Cheng, L., Ding, G., Qin, Q., Huang, Y., Lewis, W., He, N., Evans, R. M., Schneider, M. D., Brako, F. A., Xiao, Y., Chen, Y. E., and Yang, Q. (2004). Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10, 1245-1250.
74. Cheng, Q., Sedlic, F., Pravdic, D., Bosnjak, Z. J., and Kwok, W. M. (2011). Biphasic effect of nitric oxide on the cardiac voltage-dependent anion channel. FEBS Lett. 585, 328-334.
75. Cho, S., Szeto, H. H., Kim, E., Kim, H., Tolhurst, A. T., and Pinto, J. T. (2007). A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J. Biol. Chem. 282, 4634-4642.
76. Cohen, G., and Kesler, N. (1999a). Monoamine oxidase and mitochondrial respiration. J. Neurochem. 73, 2310-2315.
77. Cohen, G., and Kesler, N. (1999b). Monoamine oxidase inhibits mitochondrial respiration. Ann. N. Y. Acad. Sci. 893, 273-278.
78. Collins, T. J., Berridge, M. J., Lipp, P., and Bootman, M. D. (2002). Mitochondria are morphologically and functionally heterogeneous within cells. EMBO J. 21, 1616-1627.
79. Cooper, C. E., and Brown, G. C. (2008). The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J. Bioenerg. Biomembr. 40, 533-539.
80. Cortassa, S., Aon, M., Iglesisa, A., and Llyod, D. (2002). An Introduction to Metabolic and Cellular Engineering. Singapore: World Scientific, 244.
81. Cortassa, S., O'Rourke, B., Winslow, R. L., and Aon, M. A. (2009). Control and regulation of mitochondrial energetics in an integrated model of cardiomyocyte function. Biophys. J. 96, 2466-2478.
82. Costantini, P., Jacotot, E., Decaudin, D., and Kroemer, G. (2000). Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 92, 1042-1053.
83. 2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem. J. 245, 915-918.
84. Csiszar, A., Labinskyy, N., Olson, S., Pinto, J. T., Gupte, S., Wu, J. M., Hu, F., Ballabh, P., Podlutsky, A., Losonczy, G., de Cabo, R., Mathew, R., Wolin, M. S., and Ungvari, Z. (2009a). Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 54, 668-675.
85. Csiszar, A., Labinskyy, N., Pinto, J. T., Ballabh, P., Zhang, H., Losonczy, G., Pearson, K., de Cabo, R., Pacher, P., Zhang, C., and Ungvari, Z. (2009b). Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 297, H13-H20.
86. Csordas, G., Thomas, A. P., and Hajnoczky, G. (2001). Calcium signal transmission between ryanodine receptors and mitochondria in cardiac muscle. Trends Cardiovasc. Med. 11, 269-275.
87. Czaja, M. J., Xu, J., Ju, Y., Alt, E., and Schmiedeberg, P. (1994). Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration. Hepatology 19, 1282-1289.
88. Dalen, H. (1989). An ultrastructural study of the hypertrophied human papillary muscle cell with special emphasis on specific staining patterns, mitochondrial projections and association between mitochondria and SR. Virchows Arch. A, Pathol. Anat. Histopathol. 414, 187-198.
89. Das, D. K., Mukherjee, S., and Ray, D. (2010). Resveratrol and red wine, healthy heart and longevity. Heart Fail. Rev. 15, 467-477.
90. Das, S., Wong, R., Rajapakse, N., Murphy, E., and Steenbergen, C. (2008). Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ. Res. 103, 983-991.
91. Davidson, S. M., and Duchen, M. R. (2007). Endothelial mitochondria: contributing to vascular function and disease. Circ. Res. 100, 1128-1141.
92. Deierborg, T., Wieloch, T., Diano, S., Warden, C. H., Horvath, T. L., and Mattiasson, G. (2008). Overexpression of UCP2 protects thalamic neurons following global ischemia in the mouse. J. Cereb. Blood Flow Metab. 28, 1186-1195.
93. Di Lisa, F., and Bernardi, P. (2006). Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc. Res. 70, 191-199.
94. Di Lisa, F., Kaludercic, N., Carpi, A., Menabo, R., and Giorgio, M. (2009). Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res. Cardiol. 104, 131-139.
95. + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571-2575.
96. Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G., and Dikalov, S. I. (2010). Therapeutic tar-geting of mitochondrial superoxide in hypertension. Circ. Res. 107, 106-116.
97. Dobsak, P., Siegelova, J., Wolf, J. E., Rochette, L., Eicher, J. C., Vasku, J., Kuchtickova, S., and Horky, M. (2002). Prevention of apoptosis by deferoxamine during 4 hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model. Pathophysiology 9, 27.
98. Dolder, M., Walzel, B., Speer, O., Schlattner, U., and Wallimann, T. (2003). Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J. Biol. Chem. 278, 17760-17766.
99. Don, A. S., Kisker, O., Dilda, P., Donoghue, N., Zhao, X., Decollogne, S., Creighton, B., Flynn, E., Folkman, J., and Hogg, P. J. (2003). A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer Cell 3, 497-509.
100. Dorn, G. W. II, and Scorrano, L. (2010). Two close, too close: sarcoplasmic reticulum-mitochondrial crosstalk and cardiomyocyte fate. Circ. Res. 107, 689-699.
101. Dorner, A., Schulze, K., Rauch, U., and Schultheiss, H. P. (1997). Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol. Cell. Biochem. 174, 261-269.
102. Doughan, A. K., Harrison, D. G., and Dikalov, S. I. (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102, 488-496.
103. Du, W., Li, W., Chen, G., Cao, H., Tang, H., Tang, X., Jin, Q., Sun, Z., Zhao, H., Zhou, W., He, S., Lv, Y., Zhao, J., and Zhang, X. (2008). Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology. Biosens. Bioelectron. 24, 2371-2376.
104. Duchen, M. R. (2004). Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol. Aspects Med. 25, 365-451.
105. Duckles, S. P., Krause, D. N., Stirone, C., and Procaccio, V. (2006). Estrogen and mitochondria: a new paradigm for vascular protection? Mol. Interv. 6, 26-35.
106. Duda, M. K., O'Shea, K. M., Lei, B., Barrows, B. R., Azimzadeh, A. M., McElfresh, T. E., Hoit, B. D., Kop, W. J., and Stanley, W. C. (2008). Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J. Card. Fail. 14, 327-335.
107. Ebrahimian, T., Sairam, M. R., Schiffrin, E. L., and Touyz, R. M. (2008). Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause. Am. J. Physiol. Heart Circ. Physiol. 295, H1481-H1488.
108. Ebrahimian, T., and Touyz, R. M. (2008). Thioredoxin in vascular biology: role in hypertension. Antioxid. Redox Signal. 10, 1127-1136.
109. Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero-Otin, M., Pamplona, R., Vidal-Puig, A. J., Wang, S., Roebuck, S. J., and Brand, M. D. (2003). A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22, 4103-4110.
110. Eells, J. T., Wong-Riley, M. T., VerHoeve, J., Henry, M., Buchman, E. V., Kane, M. P., Gould, L. J., Das, R., Jett, M., Hodgson, B. D., Margolis, D., and Whelan, H. T. (2004). Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 4, 559-567.
111. England, P. J., and Randle, P. J. (1967). Effectors of rat-heart hexokinases and the control of rates of glucose phosphorylation in the perfused rat heart. Biochem. J. 105, 907-920.
112. Fell, D. (1996). Understanding the Control of Metabolism. London: Portland Press.
113. Fell, D. A. (1992). Metabolic control analysis: a survey of its theoretical and experimental development. Biochem. J. 286(Pt 2), 313-330.
114. Ferdinandy, P., and Schulz, R. (2003). Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 138, 532-543.
115. Fiskum, G., Rosenthal, R. E., Vereczki, V., Martin, E., Hoffman, G. E., Chinopoulos, C., and Kowaltowski, A. (2004). Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J. Bioenerg. Biomembr. 36, 347-352.
116. Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G. V., Rudka, T., Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B., and Scorrano, L. (2006). OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177-189.
117. Fruehauf, J. P., and Meyskens, F. L. Jr. (2007). Reactive oxygen species: a breath of life or death? Clin. Cancer Res. 13, 789-794. [Review].
118. Fulda, S., Galluzzi, L., and Kroemer, G. (2010). Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 9, 447-464.
119. Gadicherla, A., Yang, M., Camara, A., Aldakkak, M., Boelens, A., Wakim, B., and Stowe, D. (2010). Ranolazine preserves the integrity of mitochondrial supercomplexes. Biophys. J. 98, 56a. [Abstract].
120. Galluzzi, L., Kepp, O., Tajeddine, N., and Kroemer, G. (2008). Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 27, 4633-4635.
121. Ganote, C. E., Worstell, J., and Kaltenbach, J. P. (1976). Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts. Am. J. Pathol. 84, 327-350.
122. Garland, P. B., Randle, P. J., and Newsholme, E. A. (1963). Citrate as an intermediary in the inhibition of phosphofructokinase in rat heart muscle by fatty acids, ketone bodies, pyruvate, diabetes, and starvation. Nature 200, 169-170.
123. Garlid, K. D., Dos Santos, P., Xie, Z. J., Costa, A. D., and Paucek, P. (2003). Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K+ channel in cardiac function and cardioprotection. Biochim. Biophys. Acta 1606, 1-21.
124. Garnier, A., Fortin, D., Delomenie, C., Momken, I., Veksler, V., and Ventura-Clapier, R. (2003). Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551(Pt 2), 491-501.
125. Gladwin, M. T., and Kim-Shapiro, D. B. (2008). The functional nitrite reductase activity of the heme-globins. Blood 112, 2636-2647.
126. Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2009). Mitochondria as targets for cancer chemotherapy. Semin. Cancer Biol. 19, 57-66.
127. Gomez, L., Li, B., Mewton, N., Sanchez, I., Piot, C., Elbaz, M., and Ovize, M. (2009). Inhibition of mitochondrial permeability transition pore opening: translation to patients. Cardiovasc. Res. 83, 226-233.
128. Gong, G., Liu, J., Liang, P., Guo, T., Hu, Q., Ochiai, K., Hou, M., Ye, Y., Wu, X., Mansoor, A., From, A. H., Ugurbil, K., Bache, R. J., and Zhang, J. (2003). Oxidative capacity in failing hearts. Am. J. Physiol. Heart Circ. Physiol. 285, H541-H548.
129. Gorbunov, N. V., Osipov, A. N., Day, B. W., Zayas-Rivera, B., Kagan, V. E., and Elsayed, N. M. (1995). Reduction of ferrylmyoglobin and ferrylhemoglobin by nitric oxide: a protective mechanism against ferryl hemoprotein-induced oxidations. Biochemistry 34, 6689-6699.
130. Gorbunov, N. V., Yalowich, J. C., Gaddam, A., Thampatty, P., Ritov, V. B., Kisin, E. R., Elsayed, N. M., and Kagan, V. E. (1997). Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence. J. Biol. Chem. 272, 12328-12341.
131. Guo, J., Gertsberg, Z., Ozgen, N., and Steinberg, S. F. (2009). p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Circ. Res. 104, 660-669.
132. Haines, B. A., Mehta, S. L., Pratt, S. M., Warden, C. H., and Li, P. A. (2010). Deletion of mitochondrial uncoupling protein-2 increases ischemic brain damage after transient focal ischemia by altering gene expression patterns and enhancing inflammatory cytokines. J. Cereb. Blood Flow Metab. 30, 1825-1833.
133. Hajnoczky, G., and Csordas, G. (2010). Calcium signalling: fishing out molecules of mitochondrial calcium transport. Curr. Biol. 20, R888-R891.
134. Halestrap, A. P. (2010). A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem. Soc. Trans. 38, 841-860.
135. Halestrap, A. P., Clarke, S. J., and Javadov, S. A. (2004). Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc. Res. 61, 372-385.
136. Halestrap, A. P., Clarke, S. J., and Khaliulin, I. (2007). The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta 1767, 1007-1031.
137. Hallen, S., and Brzezinski, P. (1994). Light-induced structural changes in cytochrome c oxidase: implication for the mechanism of electron and proton gating. Biochim. Biophys. Acta 1184, 207-218.
138. Hallen, S., Oliveberg, M., and Brzezinski, P. (1993). Light-induced structural changes in cytochrome c oxidase. Measurements of electrogenic events and absorbance changes. FEBS Lett. 318, 134-138.
139. Hanley, P. J., and Daut, J. (2005). KATP channels and preconditioning: a re-examination of the role of mitochondrial KATP channels and an overview of alternative mechanisms. J. Mol. Cell. Cardiol. 39, 17-50.
140. Hanley, P. J., Gopalan, K. V., Lareau, R. A., Srivastava, D. K., von Meltzer, M., and Daut, J. (2003). Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J. Physiol. 547(Pt 2), 387-393.
141. Hanley, P. J., Mickel, M., Loffler, M., Brandt, U., and Daut, J. (2002). KATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J. Physiol. 542(Pt 3), 735-741.
142. Hanukoglu, I., and Rapoport, R. (1995). Routes and regulation of NADPH pro-duction in steroidogenic mitochondria. Endocr. Res. 21, 231-241.
143. Harrois, A., Huet, O., and Duranteau, J. (2009). Alterations of mitochondrial function in sepsis and critical illness. Curr. Opin. Anaesthesiol. 22, 143-149.
144. Hausladen, A., and Fridovich, I. (1994). Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269, 29405-29408.
145. Hayashida, K., Sano, M., Ohsawa, I., Shinmura, K., Tamaki, K., Kimura, K., Endo, J., Katayama, T., Kawamura, A., Kohsaka, S., Makino, S., Ohta, S., Ogawa, S., and Fukuda, K. (2008). Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 373, 30-35.
146. + influx increases respiration and enhances ROS production while maintaining membrane potential. Am. J. Physiol. Cell Physiol. 292, C148-C156.
147. Heinrich, R., and Rapoport, T. A. (1974). A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur. J. Biochem. 42, 89-95.
148. Hendgen-Cotta, U. B., Merx, M. W., Shiva, S., Schmitz, J., Becher, S., Klare, J. P., Steinhoff, H. J., Goedecke, A., Schrader, J., Gladwin, M. T., Kelm, M., and Rassaf, T. (2008). Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 105, 10256-10261.
149. Honda, H. M., Korge, P., and Weiss, J. N. (2005). Mitochondria and ischemia/ reperfusion injury. Ann. N. Y. Acad. Sci. 1047, 248-258.
150. Hoppe, U. C. (2010). Mitochondrial calcium channels. FEBS Lett. 584, 1975-1981.
151. Hoye, A. T., Davoren, J. E., Wipf, P., Fink, M. P., and Kagan, V. E. (2008). Targeting mitochondria. Acc. Chem. Res. 41, 87-97.
152. Ide, T., Tsutsui, H., Hayashidani, S., Kang, D., Suematsu, N., Nakamura, K., Utsumi, H., Hamasaki, N., and Takeshita, A. (2001). Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 88, 529-535.
153. James, A. M., Cocheme, H. M., Smith, R. A., and Murphy, M. P. (2005). Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 280, 21295-21312.
154. Javadov, S., Choi, A., Rajapurohitam, V., Zeidan, A., Basnakian, A. G., and Karmazyn, M. (2008). NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc. Res. 77, 416-424.
155. Jezek, P., Engstova, H., Zackova, M., Vercesi, A. E., Costa, A. D., Arruda, P., and Garlid, K. D. (1998). Fatty acid cycling mechanism and mitochondrial uncoupling proteins. Biochim. Biophys. Acta 1365, 319-327.
156. Jin, Z. Q., Zhou, H. Z., Cecchini, G., Gray, M. O., and Karliner, J. S. (2005). MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 288, H2986-H2994.
157. Jones, S. P., Teshima, Y., Akao, M., and Marban, E. (2003). Simvastatin attenuates oxidant-induced mitochondrial dysfunction in cardiac myocytes. Circ. Res. 93, 697-699.
158. Kacser, H., and Burns, J. A. (1973). The control of flux. Symp. Soc. Exp. Biol. 27, 65-104.
159. Kaludercic, N., Carpi, A., Menabo, R., Di Lisa, F., and Paolocci, N. (2010a). Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. Biochim. Biophys. Acta. PMID 20975995.
160. Kaludercic, N., Takimoto, E., Nagayama, T., Feng, N., Lai, E. W., Bedja, D., Chen, K., Gabrielson, K. L., Blakely, R. D., Shih, J. C., Pacak, K., Kass, D. A., Di Lisa, F., and Paolocci, N. (2010b). Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ. Res. 106, 193-202.
161. Karu, T. I. (2008). Mitochondrial signaling in mammalian cells activated by red and near-IR radiation. Photochem. Photobiol. 84, 1091-1099.
162. Karu, T. I., Pyatibrat, L. V., and Afanasyeva, N. I. (2004). A novel mitochondrial signaling pathway activated by visible-to-near infrared radiation. Photochem. Photobiol. 80, 366-372.
163. Karu, T., Pyatibrat, L., and Kalendo, G. (1995). Irradiation with He-Ne laser increases ATP level in cells cultivated in vitro. J. Photochem. Photobiol. B Biol. 27, 219-223.
164. Kasamaki, Y., Guo, A. C., and McDonald, T. F. (1997). Protection by hypoxic preconditioning against hypoxia-reoxygenation injury in guinea-pig papillary muscles. Cardiovasc. Res. 34, 313-322.
165. Katz, L. A., Swain, J. A., Portman, M. A., and Balaban, R. S. (1989). Relation between phosphate metabolites and oxygen consumption of heart in vivo. Am. J. Physiol. 256(Pt 2), H265-H274.
166. Kerner, J., Zaluzec, E., Gage, D., and Bieber, L. L. (1994). Characterization of the malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo) of a rat heart mitochondrial particle. Evidence that the catalytic unit is CPTi. J. Biol. Chem. 269, 8209-8219.
167. Kevin, L. G., Camara, A. K., Riess, M. L., Novalija, E., and Stowe, D. F. (2003). Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am. J. Physiol. Heart Circ. Physiol. 284, H566-H574.
168. Kibbey, R. G., Pongratz, R. L., Romanelli, A. J., Wollheim, C. B., Cline, G. W., and Shulman, G. I. (2007). Mitochondrial GTP regulates glucose-stimulated insulin secretion. Cell Metab. 5, 253-264.
169. Kim, G. T., Chun, Y. S., Park, J. W., and Kim, M. S. (2003). Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem. Biophys. Res. Commun. 309, 619-624.
170. Kim, Y. M., Bombeck, C. A., and Billiar, T. R. (1999). Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 84, 253-256.
171. Kimura, Y., and Kimura, H. (2004). Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 18, 1165-1167.
172. Kindler, D. D., Thiffault, C., Solenski, N. J., Dennis, J., Kostecki, V., Jenkins, R., Keeney, P. M., and Bennett, J. P. Jr. (2003). Neurotoxic nitric oxide rapidly depolarizes and permeabilizes mitochondria by dynamically opening the mitochondrial transition pore. Mol. Cell. Neurosci. 23, 559-573.
173. Kolwicz, S. C. Jr., and Tian, R. (2009). Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization? Trends Cardiovasc. Med. 19, 201-207.
174. Koopman, W. J., Nijtmans, L. G., Dieteren, C. E., Roestenberg, P., Valsecchi, F., Smeitink, J. A., and Willems, P. H. (2010). Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid. Redox Signal. 12, 1431-1470.
175. Korzeniewski, B., Noma, A., and Matsuoka, S. (2005). Regulation of oxidative phosphorylation in intact mammalian heart in vivo. Biophys. Chem. 116, 145-157.
176. Kroemer, G., Galluzzi, L., and Brenner, C. (2007). Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163.
177. Kwong, J. Q., Henning, M. S., Starkov, A. A., and Manfredi, G. (2007). The mitochondrial respiratory chain is a modulator of apoptosis. J. Cell Biol. 179, 1163-1177.
178. Lam, A., and Lopaschuk, G. D. (2007). Anti-anginal effects of partial fatty acid oxidation inhibitors. Curr. Opin. Pharmacol. 7, 179-185.
179. Laskowski, K. R., and Russell III.R. R. (2008). Uncoupling proteins in heart failure. Curr. Heart Fail Rep. 5, 75-79.
180. Lavitrano, M., Smolenski, R. T., Musumeci, A., Maccherini, M., Slominska, E., Di Florio, E., Bracco, A., Mancini, A., Stassi, G., Patti, M., Giovannoni, R., Froio, A., Simeone, F., Forni, M., Bacci, M. L., D'Alise, G., Cozzi, E., Otterbein, L. E., Yacoub, M. H., Bach, F. H., and Calise, F. (2004). Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J. 18, 1093-1095.
181. Lefer, D. J. (2007). A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc. Natl. Acad. Sci. U.S.A. 104, 17907-17908.
182. Lenaz, G., Baracca, A., Barbero, G., Bergamini, C., Dalmonte, M. E., Del Sole, M., Faccioli, M., Falasca, A., Fato, R., Genova, M. L., Sgarbi, G., and Solaini, G. (2010). Mitochondrial respiratory chain super-complex I-III in physiology and pathology. Biochim. Biophys. Acta 1797, 633-640.
183. Lenaz, G., and Genova, M. L. (2010). Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject. Antioxid. Redox Signal. 12, 961-1008.
184. Lenka, N., Vijayasarathy, C., Mullick, J., and Avadhani, N. G. (1998). Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog. Nucleic Acid Res. Mol. Biol. 61, 309-344.
185. Lesnefsky, E. J., Moghaddas, S., Tandler, B., Kerner, J., and Hoppel, C. L. (2001). Mitochondrial dysfunction in cardiac disease: ischemia - reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 33, 1065-1089.
186. Lesnefsky, E. J., Repine, J. E., and Horwitz, L. D. (1990). Deferoxamine pretreatment reduces canine infarct size and oxidative injury. J. Pharmacol. Exp. Ther. 253, 1103-1109.
187. Li, C. J., Zhang, Q. M., Li, M. Z., Zhang, J. Y., Yu, P., and Yu, D. M. (2009). Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. Chin. Med. J. 122, 2580-2586.
188. Li, J., Donath, S., Li, Y., Qin, D., Prabhakar, B. S., and Li, P. (2010). miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet. 6, e1000795. doi: 10.1371/journal.pgen.1000795
189. Li, Q., Sato, E. F., Kira, Y., Nishikawa, M., Utsumi, K., and Inoue, M. (2006). A possible cooperation of SOD1 and cytochrome c in mitochondria-dependent apoptosis. Free Radic. Biol. Med. 40, 173-181.
190. Liachenko, S., Tang, P., and Xu, Y. (2003). Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats. J. Cereb. Blood Flow Metab. 23, 574-581.
191. Liang, H. L., Sedlic, F., Bosnjak, Z., and Nilakantan, V. (2010). SOD1 and MitoTEMPO partially prevent MPTP, necrosis and mitochondrial apoptosis following ATP depletion-recovery. Free Radic. Biol. Med. 49, 1550-1560.
192. Lin, M. T., and Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
193. Loeb, L. A., Wallace, D. C., and Martin, G. M. (2005). The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc. Natl. Acad. Sci. U.S.A. 102, 18769-18770.
194. Lohr, N. L., Keszler, A., Pratt, P., Bienengraber, M., Warltier, D. C., and Hogg, N. (2009). Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. J. Mol. Cell. Cardiol. 47, 256-263.
195. Lu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., Li, J., Huang, Y., Zhang, P., Zhao, B., and Chen, Y. (2010). PGC-1alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid. Redox Signal. 13, 1011-1022.
196. Mao, W., Iwai, C., Liu, J., Sheu, S. S., Fu, M., and Liang, C. S. (2008). Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways. J. Mol. Cell. Cardiol. 45, 250-260.
197. Marin-Garcia, J., and Goldenthal, M. J. (2008). Mitochondrial centrality in heart failure. Heart Fail. Rev. 13, 137-150.
198. Maroz, A., Anderson, R. F., Smith, R. A., and Murphy, M. P. (2009). Reactivity of ubiquinone and ubiquinol with superoxide and the hydroperoxyl radical: implications for in vivo antioxidant activity. Free Radic. Biol. Med. 46, 105-109.
199. Martinez-Ruiz, G., Maldonado, V., Ceballos-Cancino, G., Grajeda, J. P., and Melendez-Zajgla, J. (2008). Role of Smac/DIABLO in cancer progression. J. Exp. Clin. Cancer Res. 27, 48.
200. Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J. M., Susin, S. A., Vieira, H. L., Prevost, M. C., Xie, Z., Matsuyama, S., Reed, J. C., and Kroemer, G. (1998). Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027-2031.
201. Mathupala, S. P., Ko, Y. H., and Pedersen, P. L. (2009). Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin. Cancer Biol. 19, 17-24.
202. Matsukawa, N., Yasuhara, T., Hara, K., Xu, L., Maki, M., Yu, G., Kaneko, Y., Ojika, K., Hess, D. C., and Borlongan, C. V. (2009). Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci. 10, 126. doi: 10.1186/1471-2202-10-126
203. McBride, H. M., Neuspiel, M., and Wasiak, S. (2006). Mitochondria: more than just a powerhouse. Curr. Biol. 16, R551-R560.
204. McCormack, J. G., Halestrap, A. P., and Denton, R. M. (1990). Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 70, 391-425.
205. Meyer, L. E., Machado, L. B., Santiago, A. P., da-Silva, W. S., De Felice, F. G., Holub, O., Oliveira, M. F., and Galina, A. (2006). Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity. J. Biol. Chem. 281, 37361-37371.
206. Milagros Rocha, M., and Victor, V. M. (2007). Targeting antioxidants to mitochondria and cardiovascular diseases: the effects of mitoquinone. Med. Sci. Monit. 13, RA132-RA145.
207. Morin, C., Zini, R., Albengres, E., Bertelli, A. A., Bertelli, A., and Tillement, J. P. (2003a). Evidence for resveratrol-induced preservation of brain mitochondria functions after hypoxia-reoxygenation. Drugs Exp. Clin. Res. 29, 227-233.
208. Morin, C., Zini, R., and Tillement, J. P. (2003b). Anoxia-reoxygenation-induced cytochrome c and cardiolipin release from rat brain mitochondria. Biochem. Biophys. Res. Commun. 307, 477-482.
209. Morin, D., Assaly, R., Paradis, S., and Berdeaux, A. (2009). Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr. Med. Chem. 16, 4382-4398.
210. Muoio, D. M., and Newgard, C. B. (2008). Fatty acid oxidation and insulin action: when less is more. Diabetes 57, 1455-1456.
211. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ. Res. 89, 891-898.
212. Muravchick, S., and Levy, R. J. (2006). Clinical implications of mitochondrial dysfunction. Anesthesiology 105, 819-837.
213. Murray, A. J., Edwards, L. M., and Clarke, K. (2007). Mitochondria and heart failure. Curr. Opin. Clin. Nutr. Metab. Care 10, 704-711.
214. Nadtochiy, S. M., Burwell, L. S., and Brookes, P. S. (2007). Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 42, 812-825.
215. Navarro, A., and Boveris, A. (2009). Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease. J. Bioenerg. Biomembr. 41, 517-521.
216. Nediani, C., Raimondi, L., Borchi, E., and Cerbai, E. (2011). Nitric oxide/reactive oxygen species generation and nitroso/ redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid. Redox Signal. 14, 289-331.
217. Neely, J. R., Denton, R. M., England, P. J., and Randle, P. J. (1972). The effects of increased heart work on the tricarboxylate cycle and its interactions with glycolysis in the perfused rat heart. Biochem. J. 128, 147-159.
218. Neely, J. R., and Morgan, H. E. (1974). Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu. Rev. Physiol. 36, 413-459.
219. Neubauer, S. (2007). The failing heart-an engine out of fuel. N. Engl. J. Med. 356, 1140-1151.
220. Newsholm, E., and Start, C. (1973). Regulation in Metabolism, Chapter 5. London: John Wiley and Sons. Nicholls, D., and Fergunson, S. J. (2002). Bioenergetics. London: Academic Press.
221. Nishihara, M., Miura, T., Miki, T., Tanno, M., Yano, T., Naitoh, K., Ohori, K., Hotta, H., Terashima, Y., and Shimamoto, K. (2007). Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J. Mol. Cell. Cardiol. 43, 564-570.
222. Norberg, E., Orrenius, S., and Zhivotovsky, B. (2010). Mitochondrial regulation of cell death: processing of apoptosis-inducing factor (AIF). Biochem. Biophys. Res. Commun. 396, 95-100.
223. Nossuli, T. O., Hayward, R., Jensen, D., Scalia, R., and Lefer, A. M. (1998). Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am. J. Physiol. 275(Pt 2), H509-H519.
224. Ochiai, K., Zhang, J., Gong, G., Zhang, Y., Liu, J., Ye, Y., Wu, X., Liu, H., Murakami, Y., Bache, R. J., Ugurbil, K., and From, A. H. (2001). Effects of augmented delivery of pyruvate on myocardial high-energy phosphate metabolism at high workstate. Am. J. Physiol. Heart Circ. Physiol. 281, H1823-H1832.
225. O'Connor, P. M., and Gutterman, D. D. (2010). Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria. Circ. Res. 107, 9-11.
226. Okada, S. F., O'Neal, W. K., Huang, P., Nicholas, R. A., Ostrowski, L. E., Craigen, W. J., Lazarowski, E. R., and Boucher, R. C. (2004). Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells. J. Gen. Physiol. 124, 513-526.
227. Ong, S. B., and Hausenloy, D. J. (2010). Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 88, 16-29.
228. Opie, L. (1998). Heart Physiology: From Cell to Circulation. Philadelphia: Lippincott-Raven Publishers, 44-63.
229. Opie, L. H. (1965). Coronary flow rate and perfusion pressure as determinants of mechanical function and oxidative metabolism of isolated perfused rat heart. J. Physiol. 180, 529-541.
230. Oram, J. F., Bennetch, S. L., and Neely, J. R. (1973). Regulation of fatty acid utilization in isolated perfused rat hearts. J. Biol. Chem. 248, 5299-5309.
231. Oron, U., Yaakobi, T., Oron, A., Mordechovitz, D., Shofti, R., Hayam, G., Dror, U., Gepstein, L., Wolf, T., Haudenschild, C., and Haim, S. B. (2001). Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation 103, 296-301.
232. O'Rourke, B. (2007). Mitochondrial ion channels. Annu. Rev. Physiol. 69, 19-49.
233. Osipov, A. N., Stepanov, G. O., Vladimirov, Y. A., Kozlov, A. V., and Kagan, V. E. (2006). Regulation of cytochrome C peroxidase activity by nitric oxide and laser irradiation. Biochemistry (Mosc). 71, 1128-1132.
234. Outten, C. E., and Culotta, V. C. (2003). A novel NADH kinase is the mitochondrial source of NADPH in Saccharomyces cerevisiae. EMBO J. 22, 2015-2024.
235. Owen, M. R., Doran, E., and Halestrap, A. P. (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348(Pt 3), 607-614.
236. Papa, S., De Rasmo, D., Scacco, S., Signorile, A., Technikova-Dobrova, Z., Palmisano, G., Sardanelli, A. M., Papa, F., Panelli, D., Scaringi, R., and Santeramo, A. (2008). Mammalian complex I: a regulable and vulnerable pacemaker in mitochondrial respiratory function. Biochim. Biophys. Acta 1777, 719-728.
237. 2+ in mitochondrial dysfunction and disease. Cell Calcium 45, 643-650.
238. Paradies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A., and Ruggiero, F. M. (2004). Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ. Res. 94, 53-59.
239. Paradies, G., Petrosillo, G., and Ruggiero, F. M. (1997). Cardiolipin-dependent decrease of cytochrome c oxidase activity in heart mitochondria from hypothyroid rats. Biochim. Biophys. Acta 1319, 5-8.
240. Pastorino, J. G., and Hoek, J. B. (2008). Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr. 40, 171-182.
241. Pastorino, J. G., Hoek, J. B., and Shulga, N. (2005). Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 65, 10545-10554.
242. Pedersen, P. L., Mathupala, S., Rempel, A., Geschwind, J. F., and Ko, Y. H. (2002). Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta 1555, 14-20.
243. Pereira, C. V., Moreira, A. C., Pereira, S. P., Machado, N. G., Carvalho, F. S., Sardao, V. A., and Oliveira, P. J. (2009). Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? Curr. Drug Saf. 4, 34-54.
244. Petrosillo, G., Colantuono, G., Moro, N., Ruggiero, F. M., Tiravanti, E., Di Venosa, N., Fiore, T., and Paradies, G. (2009). Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am. J. Physiol. Heart Circ. Physiol. 297, H1487-H1493.
245. Phillips, D., Aponte, A. M., French, S. A., Chess, D. J., and Balaban, R. S. (2009). Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. Biochemistry 48, 7140-7149.
246. Piantadosi, C. A., Carraway, M. S., Babiker, A., and Suliman, H. B. (2008). Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103, 1232-1240.
247. Piao, L., Fang, Y. H., Cadete, V. J., Wietholt, C., Urboniene, D., Toth, P. T., Marsboom, G., Zhang, H. J., Haber, I., Rehman, J., Lopaschuk, G. D., and Archer, S. L. (2010). The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J. Mol. Med. 88, 47-60.
248. Pinton, P., Rimessi, A., Marchi, S., Orsini, F., Migliaccio, E., Giorgio, M., Contursi, C., Minucci, S., Mantovani, F., Wieckowski, M. R., Del Sal, G., Pelicci, P. G., and Rizzuto, R. (2007). Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315, 659-663.
249. Pipinos, I. I., Judge, A. R., Zhu, Z., Selsby, J. T., Swanson, S. A., Johanning, J. M., Baxter, B. T., Lynch, T. G., and Dodd, S. L. (2006). Mitochondrial defects and oxidative damage in patients with peripheral arterial disease. Free Radic. Biol. Med. 41, 262-269.
250. Pope, S., Land, J. M., and Heales, S. J. (2008). Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target? Biochim. Biophys. Acta 1777, 794-799.
251. Pravdic, D., Mio, Y., Sedlic, F., Pratt, P. F., Warltier, D. C., Bosnjak, Z. J., and Bienengraeber, M. (2010). Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion. Br. J. Pharmacol. 160, 220-232.
252. Radi, R., Peluffo, G., Alvarez, M. N., Naviliat, M., and Cayota, A. (2001). Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30, 463-488.
253. Randle, P. J. (1998). Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14, 263-283.
254. Randle, P. J., England, P. J., and Denton, R. M. (1970). Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart. Biochem. J. 117, 677-695.
255. Randle, P. J., Garland, P. B., Hales, C. N., and Newsholme, E. A. (1963). The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
256. Raval, A. P., Lin, H. W., Dave, K. R., Defazio, R. A., Della Morte, D., Kim, E. J., and Perez-Pinzon, M. A. (2008). Resveratrol and ischemic preconditioning in the brain. Curr. Med. Chem. 15, 1545-1551.
257. Raymond, G., and Potreau, D. (1977). Barium ions and excitation-contraction coupling of frog single muscle fibres under controlled current and voltage. J. Physiol. (Paris) 73, 617-631.
258. oC ischemia in intact hearts. Cardiovasc. Res. 61, 580-590.
259. 2+ transfer from the ER to mitochondria: when, how and why. Biochim. Biophys. Acta 1787, 1342-1351.
260. Rogers, R. J., Monnier, J. M., and Nick, H. S. (2001). Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. J. Biol. Chem. 276, 20419-20427.
261. Romagnoli, A., Aguiari, P., De Stefani, D., Leo, S., Marchi, S., Rimessi, A., Zecchini, E., Pinton, P., and Rizzuto, R. (2007). Endoplasmic reticulum/ mitochondria calcium cross-talk. Novartis Found. Symp. 287, 122-131; discussion 131-139.
262. Ronson, R. S., Nakamura, M., and Vinten-Johansen, J. (1999). The cardiovascular effects and implications of peroxynitrite. Cardiovasc. Res. 44, 47-59.
263. Rosca, M. G., Vazquez, E. J., Kerner, J., Parland, W., Chandler, M. P., Stanley, W., Sabbah, H. N., and Hoppel, C. L. (2008). Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc. Res. 80, 30-39.
264. Ruiz-Meana, M., Fernandez-Sanz, C., and Garcia-Dorado, D. (2010). The SR-mitochondria interaction: a new player in cardiac pathophysiology. Cardiovasc. Res. 88, 30-39.
265. Ruiz-Meana, M., Garcia-Dorado, D., Pina, P., Inserte, J., Agullo, L., and Soler-Soler, J. (2003). Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions. Am. J. Physiol. Heart Circ. Physiol. 285, H999-H1006.
266. Rybnikova, E., Damdimopoulos, A. E., Gustafsson, J. A., Spyrou, G., and Pelto-Huikko, M. (2000). Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur. J. Neurosci. 12, 1669-1678.
267. Saba, H., Batinic-Haberle, I., Munusamy, S., Mitchell, T., Lichti, C., Megyesi, J., and MacMillan-Crow, L. A. (2007). Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion. Free Radic. Biol. Med. 42, 1571-1578.
268. Sack, M. N. (2006a). Exploring mitochondria in the intact ischemic heart: advancing technologies to image intracellular function. Circulation 114, 1452-1454.
269. Sack, M. N. (2006b). Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc. Res. 72, 210-219.
270. Saks, V., Dzeja, P., Schlattner, U., Vendelin, M., Terzic, A., and Wallimann, T. (2006a). Cardiac system bioenergetics: metabolic basis of the Frank-Starling law. J. Physiol. 571(Pt 2), 253-273.
271. Saks, V., Favier, R., Guzun, R., Schlattner, U., and Wallimann, T. (2006b). Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands. J. Physiol. 577(Pt 3), 769-777.
272. Saks, V. A., Kongas, O., Vendelin, M., and Kay, L. (2000). Role of the creatine/ phosphocreatine system in the regulation of mitochondrial respiration. Acta Physiol. Scand. 168, 635-641.
273. Sareen, D., Darjatmoko, S. R., Albert, D. M., and Polans, A. S. (2007). Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol. Pharmacol. 72, 1466-1475.
274. Sareen, D., van Ginkel, P. R., Takach, J. C., Mohiuddin, A., Darjatmoko, S. R., Albert, D. M., and Polans, A. S. (2006). Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 47, 3708-3716.
275. Schapira, A. H. (2006). Mitochondrial disease. Lancet 368, 70-82.
276. Schwimmer, C., Lefebvre-Legendre, L., Rak, M., Devin, A., Slonimski, P. P., di Rago, J. P., and Rigoulet, M. (2005). Increasing mitochondrial substrate-level phosphorylation can rescue respiratory growth of an ATP synthase-deficient yeast. J. Biol. Chem. 280, 30751-30759.
277. Sedlic, F., Pravdic, D., Hirata, N., Mio, Y., Sepac, A., Camara, A. K., Wakatsuki, T., Bosnjak, Z. J., and Bienengraeber, M. (2010a). Monitoring mitochondrial electron fluxes using NAD(P) H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytes. Biochim. Biophys. Acta 1797, 1749-1758.
278. 2+. Am. J. Physiol., Cell Physiol. 299, C506-C515.
279. Sen, C. K. (1998). Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55, 1747-1758.
280. Serviddio, G., Di Venosa, N., Federici, A., D'Agostino, D., Rollo, T., Prigigallo, F., Altomare, E., Fiore, T., and Vendemiale, G. (2005). Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J. 19, 354-361.
281. 2+ from sarcoplasmic reticulum to mitochondria in rat ventricular myocytes. J. Bioenerg. Biomembr. 32, 97-104.
282. Sharov, V. G., Todor, A. V., Silverman, N., Goldstein, S., and Sabbah, H. N. (2000). Abnormal mitochondrial respiration in failed human myocardium. J. Mol. Cell. Cardiol. 32, 2361-2367.
283. Shen, T., Zheng, M., Cao, C., Chen, C., Tang, J., Zhang, W., Cheng, H., Chen, K. H., and Xiao, R. P. (2007). Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J. Biol. Chem. 282, 23354-23361.
284. Shidoji, Y., Hayashi, K., Komura, S., Ohishi, N., and Yagi, K. (1999). Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem. Biophys. Res. Commun. 264, 343-347.
285. Shoshan-Barmatz, V., Keinan, N., and Zaid, H. (2008). Uncovering the role of VDAC in the regulation of cell life and death. J. Bioenerg. Biomembr.40, 183-191.
286. 2+ signals in oligodendrocyte progenitors. Cell Calcium 26, 121-130.
287. Smeele, K. M., Eerbeek, O., Koeman, A., Bezemer, R., Ince, C., Heikkinen, S., Laakso, M., de Haan, A., Schaart, G., Drost, M. R., Hollmann, M. W., and Zuurbier, C. J. (2010). Partial hexokinase II knockout results in acute ischemia-reperfusion damage in skeletal muscle of male, but not female, mice. Pflugers Arch. 459, 705-712.
288. Smith, R. A., Porteous, C. M., Coulter, C. V., and Murphy, M. P. (1999). Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem. 263, 709-716.
289. Sokol, R. J., and Treem, W. R. (1999). Mitochondria and childhood liver diseases. J. Pediatr. Gastroenterol. Nutr. 28, 4-16.
290. Solaini, G., and Harris, D. A. (2005). Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem. J. 390(Pt 2), 377-394.
291. Spasojevic, I., Chen, Y., Noel, T. J., Yu, Y., Cole, M. P., Zhang, L., Zhao, Y., St Clair, D. K., and Batinic-Haberle, I. (2007). Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria. Free Radic. Biol. Med. 42, 1193-1200.
292. Stanley, W. C., Lopaschuk, G. D., and McCormack, J. G. (1997). Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res. 34, 25-33.
293. Stanley, W. C., Recchia, F. A., and Lopaschuk, G. D. (2005). Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093-1129.
294. Starke, D. W., Chen, Y., Bapna, C. P., Lesnefsky, E. J., and Mieyal, J. J. (1997). Sensitivity of protein sulfhydryl repair enzymes to oxidative stress. Free Radic. Biol. Med. 23, 373-384.
295. + channel opening requires superoxide radical generation. Am. J. Physiol. Heart Circ. Physiol. 290, H434-H440.
296. Stowe, D. F., and Camara, A. K. S. (2009). Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function Antioxid. Redox Signal. 11, 1373-1396. [Comprehensive review].
297. Stuart, J. A., Cadenas, S., Jekabsons, M. B., Roussel, D., and Brand, M. D. (2001). Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim. Biophys. Acta 1504, 144-158.
298. Sun, H., Nikolovska-Coleska, Z., Yang, C. Y., Qian, D., Lu, J., Qiu, S., Bai, L., Peng, Y., Cai, Q., and Wang, S. (2008). Design of small-molecule peptidic and nonpeptidic Smac mimetics. Acc. Chem. Res. 41, 1264-1277.
299. 2+ signaling. Physiology (Bethesda) 23, 84-94.
300. Szabo, C., Ischiropoulos, H., and Radi, R. (2007). Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6, 662-680.
301. 2+ release and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 105, 2427-2432.
302. Szende, B., Tyihak, E., and Kiraly-Veghely, Z. (2000). Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp. Mol. Med. 32, 88-92.
303. Szeto, H. H. (2008a). Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases. Ann. N. Y. Acad. Sci. 1147, 112-121.
304. Szeto, H. H. (2008b). Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid. Redox Signal. 10, 601-619.
305. Szewczyk, A., Kajma, A., Malinska, D., Wrzosek, A., Bednarczyk, P., Zablocka, B., and Dolowy, K. (2010). Pharmacology of mitochondrial potassium channels: dark side of the field. FEBS Lett. 584, 2063-2069.
306. Taegtmeyer, H., Wilson, C. R., Razeghi, P., and Sharma, S. (2005). Metabolic energetics and genetics in the heart. Ann. N. Y. Acad. Sci. 1047, 208-218.
307. Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., and Mihara, K. (2007). Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282, 11521-11529.
308. Teshima, Y., Akao, M., Baumgartner, W. A., and Marban, E. (2003a). Nicorandil prevents oxidative stress-induced apoptosis in neurons by activating mitochondrial ATP-sensitive potassium channels. Brain Res. 990, 45-50.
309. Teshima, Y., Akao, M., Jones, S. P., and Marban, E. (2003b). Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ. Res. 93, 192-200.
310. Theruvath, T. P., Zhong, Z., Pediaditakis, P., Ramshesh, V. K., Currin, R. T., Tikunov, A., Holmuhamedov, E., and Lemasters, J. J. (2008). Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology 47, 236-246.
311. Thomas, D. A., Stauffer, C., Zhao, K., Yang, H., Sharma, V. K., Szeto, H. H., and Suthanthiran, M. (2007). Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J. Am. Soc. Nephrol. 18, 213-222.
312. Treuting, P. M., Linford, N. J., Knoblaugh, S. E., Emond, M. J., Morton, J. F., Martin, G. M., Rabinovitch, P. S., and Ladiges, W. C. (2008). Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 63, 813-822.
313. Tsutsui, H., Ide, T., and Kinugawa, S. (2006). Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid. Redox Signal. 8, 1737-1744.
314. Tuby, H., Maltz, L., and Oron, U. (2006). Modulations of VEGF and iNOS in the rat heart by low level laser therapy are associated with cardioprotection and enhanced angiogenesis. Lasers Surg. Med. 38, 682-688.
315. Turrens, J. F., Alexandre, A., and Lehninger, A. L. (1985). Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch. Biochem. Biophys. 237, 408-414.
316. Turrens, J. F., and Boveris, A. (1980). Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421-427.
317. Tuunanen, H., Engblom, E., Naum, A., Nagren, K., Hesse, B., Airaksinen, K. E., Nuutila, P., Iozzo, P., Ukkonen, H., Opie, L. H., and Knuuti, J. (2006a). Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114, 2130-2137.
318. Tuunanen, H., Engblom, E., Naum, A., Scheinin, M., Nagren, K., Airaksinen, J., Nuutila, P., Iozzo, P., Ukkonen, H., and Knuuti, J. (2006b). Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction. J. Card. Fail. 12, 644-652.
319. Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara, S., Takabayashi, A., Yamaoka, Y., and Yodoi, J. (1998). Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J. Immunol. 161, 6689-6695.
320. Ujwal, R., Cascio, D., Colletier, J. P., Faham, S., Zhang, J., Toro, L., Ping, P., and Abramson, J. (2008). The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc. Natl. Acad. Sci. U.S.A. 105, 17742-17747.
321. Vanden Hoek, T. L., Li, C., Shao, Z., Schumacker, P. T., and Becker, L. B. (1997). Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J. Mol. Cell. Cardiol. 29, 2571-2583.
322. Vendelin, M., Beraud, N., Guerrero, K., Andrienko, T., Kuznetsov, A. V., Olivares, J., Kay, L., and Saks, V. A. (2005). Mitochondrial regular arrangement in muscle cells: a "crystal-like" pattern. Am. J. Physiol. Cell Physiol. 288, C757-C767.
323. Vijayasarathy, C., Biunno, I., Lenka, N., Yang, M., Basu, A., Hall, I. P., and Avadhani, N. G. (1998). Variations in the subunit content and catalytic activity of the cytochrome c oxidase complex from different tissues and different cardiac compartments. Biochim. Biophys. Acta 1371, 71-82.
324. Vlasova, I. I., Tyurin, V. A., Kapralov, A. A., Kurnikov, I. V., Osipov, A. N., Potapovich, M. V., Stoyanovsky, D. A., and Kagan, V. E. (2006). Nitric oxide inhibits peroxidase activity of cytochrome c. cardiolipin complex and blocks cardiolipin oxidation. J. Biol. Chem. 281, 14554-14562.
325. Waldmeier, P. C., Zimmermann, K., Qian, T., Tintelnot-Blomley, M., and Lemasters, J. J. (2003). Cyclophilin D as a drug target. Curr. Med. Chem. 10, 1485-1506.
326. Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., and Eppenberger, H. M. (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281(Pt 1), 21-40.
327. Walsh, C. B. S., Voronica, S., Chvanov, M., Petersen, O. H., and Tepikin, T. (2009). Modulation of calcium signalling by mitochondria. Biochim. Biophys. Acta, 1787, 1374-1382.
328. Wan, B., LaNoue, K. F., Cheung, J. Y., and Scaduto, R. C. Jr. (1989). Regulation of citric acid cycle by calcium. J. Biol. Chem. 264, 13430-13439.
329. Wang, H., Lim, P. J., Karbowski, M., and Monteiro, M. J. (2009). Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum. Mol. Genet. 18, 737-752.
330. Wang, T., Liu, B., Qin, L., Wilson, B., and Hong, J. S. (2004). Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures. J. Neuroimmunol. 147, 68-72.
331. Waypa, G. B., Marks, J. D., Mack, M. M., Boriboun, C., Mungai, P. T., and Schumacker, P. T. (2002). Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ. Res. 91, 719-726.
332. Wenzel, P., Mollnau, H., Oelze, M., Schulz, E., Wickramanayake, J. M., Muller, J., Schuhmacher, S., Hortmann, M., Baldus, S., Gori, T., Brandes, R. P., Munzel, T., and Daiber, A. (2008). First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid. Redox Signal. 10, 1435-1447.
333. Whitmer, J. T., Idell-Wenger, J. A., Rovetto, M. J., and Neely, J. R. (1978). Control of fatty acid metabolism in ischemic and hypoxic hearts. J. Biol. Chem. 253, 4305-4309.
334. Williamson, C. L., Dabkowski, E. R., Baseler, W. A., Croston, T. L., Alway, S. E., and Hollander, J. M. (2010). Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcellular spatial location. Am. J. Physiol. Heart Circ. Physiol. 298, H633-H642.
335. Williamson, J. R. (1965). Glycolytic control mechanisms. I. Inhibition of glycolysis by acetate and pyruvate in the isolated, perfused rat heart. J. Biol. Chem. 240, 2308-2321.
336. Williamson, J. R. (1966). Glycolytic control mechanisms. II. Kinetics of intermediate changes during the aerobic-anoxic transition in perfused rat heart. J. Biol. Chem. 241, 5026-5036.
337. Williamson, J. R. (1979). Mitochondrial function in the heart. Annu. Rev. Physiol. 41, 485-506.
338. Williamson, J. R., Ford, C., Illingworth, J., and Safer, B. (1976). Coordination of citric acid cycle activity with electron transport flux. Circ. Res. 38(Suppl. 1), I39-I51.
339. Wojtczak, L., and Zablocki, K. (2008). Mitochondria in cell life, death and disease. Postepy Biochem. 54, 129-141.
340. Wojtovich, A. P., and Brookes, P. S. (2009). The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channels. Basic Res. Cardiol. 104, 121-129.
341. Wolf, H. P. (1992). Possible new therapeutic approach in diabetes mellitus by inhibition of carnitine palmitoyltransferase 1 (CPT1). Horm. Metab. Res. Suppl. 26, 62-67.
342. Wong-Riley, M. T., Liang, H. L., Eells, J. T., Chance, B., Henry, M. M., Buchmann, E., Kane, M., and Whelan, H. T. (2005). Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome c oxidase. J. Biol. Chem. 280, 4761-4771.
343. Wood, K. C., and Gladwin, M. T. (2007). The hydrogen highway to reperfusion therapy. Nat. Med. 13, 673-674.
344. Wu, F., Yang, F., Vinnakota, K. C., and Beard, D. A. (2007). Computer modeling of mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite transport, and electrophysiology. J. Biol. Chem. 282, 24525-24537.
345. Wu, F., Zhang, E. Y., Zhang, J., Bache, R. J., and Beard, D. A. (2008). Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts. J. Physiol. 586(Pt 17), 4193-4208.
346. Wyatt, K. M., Skene, C., Veitch, K., Hue, L., and McCormack, J. G. (1995). The antianginal agent ranolazine is a weak inhibitor of the respiratory complex I, but with greater potency in broken or uncoupled than in coupled mitochondria. Biochem. Pharmacol. 50, 1599-1606.
347. + channels in the cardiac inner mitochondrial membrane. Science 298, 1029-1033.
348. Yu, T., Sheu, S. S., Robotham, J. L., and Yoon, Y. (2008). Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 79, 341-351.
349. Zhang, J., Gong, G., Ye, Y., Guo, T., Mansoor, A., Hu, Q., Ochiai, K., Liu, J., Wang, X., Cheng, Y., Iverson, N., Lee, J., From, A. H., Ugurbil, K., and Bache, R. J. (2005). Nitric oxide regulation of myocardial O2 consumption and HEP metabolism. Am. J. Physiol. Heart Circ. Physiol. 288, H310-H316.
350. Zhang, R., Mio, Y., Pratt, P. F., Lohr, N., Warltier, D. C., Whelan, H. T., Zhu, D., Jacobs, E. R., Medhora, M., and Bienengraeber, M. (2009). Near infrared light protects cardiomyocytes from hypoxia and reoxygenation injury by a nitric oxide dependent mechanism. J. Mol. Cell. Cardiol. 46, 4-14.
351. Zhang, W. H., Wang, H., Wang, X., Narayanan, M. V., Stavrovskaya, I. G., Kristal, B. S., and Friedlander, R. M. (2008). Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury. Stroke 39, 455-462.
352. 2 in mitochondria. J. Biol. Chem. 278, 2356-2360.
353. Zmijewski, J. W., Lorne, E., Zhao, X., Tsuruta, Y., Sha, Y., Liu, G., Siegal, G. P., and Abraham, E. (2008). Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am. J. Respir. Crit. Care Med. 178, 168-179.
354. Zoccarato, F., Cavallini, L., Bortolami, S., and Alexandre, A. (2007). Succinate modulation of H2O2 release at NADH:ubiquinone oxidoreductase (Complex I) in brain mitochondria. Biochem. J. 406, 125-129.
355. Zorov, D. B., Filburn, C. R., Klotz, L. O., Zweier, J. L., and Sollott, S. J. (2000). Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med. 192, 1001-1014.
356. Zorov, D. B., Kobrinsky, E., Juhaszova, M., and Sollott, S. J. (2004). Examining intracellular organelle function using fluorescent probes: from animalcules to quantum dots. Circ. Res. 95, 239-252.
357. Zuckerbraun, B. S., Chin, B. Y., Bilban, M., d'Avila, J. C., Rao, J., Billiar, T. R., and Otterbein, L. E. (2007). Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J. 21, 1099-1106.
358. Zuurbier, C. J., Smeele, K. M., and Eerbeek, O. (2009). Mitochondrial hexokinase and cardioprotection of the intact heart. J. Bioenerg. Biomembr. 41, 181-185.